qx-314 has been researched along with mexiletine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraoka, M; Kimura, A; Kitabatake, A; Makita, N; Sakurada, H; Sasaki, K; Shirai, N; Sunami, A; Tohse, N; Yokoi, H | 1 |
| Sasaki, K | 1 |
2 other study(ies) available for qx-314 and mexiletine
| Article | Year |
|---|---|
Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access.
Topics: Amino Acid Substitution; Anti-Arrhythmia Agents; Heart; Humans; Leucine; Lidocaine; Mexiletine; Mutation; Myocardium; Serine; Sodium Channel Blockers; Sodium Channels | 2004 |
[The filter region of the myocardial Na channel, together with ion selectivity, controls pharmacodynamics of anti-arrhythmia agents--an analysis using the channel altered by idiopathic ventricular fibrillation].
Topics: Anti-Arrhythmia Agents; Filtration; Heart; Humans; In Vitro Techniques; Lidocaine; Mexiletine; Muscle Proteins; NAV1.5 Voltage-Gated Sodium Channel; Sodium Channels; Ventricular Fibrillation | 2004 |